CBO finds health agency cuts would result in fewer new drugs
The analysis, requested by Senate and House Democrats, will likely become a main talking point for them during the fiscal 2026 appropriations process.
Search Roll Call
Search the Roll Call archive by keyword, date, Congress, section, or tags.